Showing results (151-160 of 8,931) with videos related to
Sort By:
Pageof 894
Journal of Cancer Research and Clinical Oncology|January 1, 1989
Expression of myc and ras oncogenes in two newly established neuroblastoma cell linesF Csaikl, L Müllauer, U Csaikl, et al.Journal of Cancer Research and Clinical Oncology|December 16, 2015
The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailableJujuan Wang, Dongjiao Wang, Qingbo Zhang, et al.Journal of Cancer Research and Clinical Oncology|December 10, 2015
In vivo evaluation of neutron capture therapy effectivity using calcium phosphate-based nanoparticles as Gd-DTPA delivery agentNovriana Dewi, Peng Mi, Hironobu Yanagie, et al.Journal of Cancer Research and Clinical Oncology|December 10, 2015
Cancer is associated with intraoperative and postprocedural complications and disordersLouis Jacob, Karel KostevJournal of Cancer Research and Clinical Oncology|April 28, 2022
Efficacy and safety of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer: a prospective, single-arm, phase II study in ChinaXiao Han, Jun Guo, Xiaoyong Tang, et al.Journal of Cancer Research and Clinical Oncology|July 20, 2022
PD-1 inhibitors plus chemotherapy in EGFR/ALK-positive NSCLC patients with brain metastases and disease progression after EGFR/ALK-TKIs therapyYixiang Zhu, Ye Zhang, Xingsheng Hu, et al.Journal of Cancer Research and Clinical Oncology|July 23, 2022
Advantages of organ-sparing treatment approaches in metastatic kidney cancerIurii Vitruk, Oleg Voylenko, Oleksandr Stakhovsky, et al.Journal of Cancer Research and Clinical Oncology|July 23, 2022
Clinical characteristics and long-term outcomes of rhabdomyosarcoma in Korean children, adolescents and young adults: a single-center experienceMeerim Park, Jun Ah Lee, Hye Young Jin, et al.Journal of Cancer Research and Clinical Oncology|July 24, 2022
Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancerEiji Takeuchi, Kensuke Kondo, Yoshio Okano, et al.Journal of Cancer Research and Clinical Oncology|July 14, 2022
Safety and efficacy of pembrolizumab for advanced nonsmall cell lung cancer: before and during the COVID-19 pandemicDoran Ksienski, Sapna Gupta, Pauline T Truong, et al.Pageof 894